346 related articles for article (PubMed ID: 8774070)
1. Antitumor mechanisms of zinostatin stimalamer (YM881).
Tanaka S; Yamamoto M; Numasaki Y
Res Commun Mol Pathol Pharmacol; 1996 May; 92(2):165-76. PubMed ID: 8774070
[TBL] [Abstract][Full Text] [Related]
2. [Action mechanisms of zinostatin stimalamer (YM881)].
Tanaka S; Numasaki Y; Maeda H
Gan To Kagaku Ryoho; 1991 Oct; 18(13):2295-300. PubMed ID: 1834022
[TBL] [Abstract][Full Text] [Related]
3. [Antitumor effects of a new antitumor agent, zinostatin stimalamer (YM881)--effects on experimental tumors in vitro and in vivo].
Numasaki Y; Takahashi K; Masuda E; Nohara C; Maeda H
Gan To Kagaku Ryoho; 1991 Oct; 18(13):2289-94. PubMed ID: 1834021
[TBL] [Abstract][Full Text] [Related]
4. Antitumor activity of zinostatin stimalamer (YM881) in human hepatoma cell lines and VX2 liver tumor-bearing rabbits.
Tanaka S; Fujihara A; Yamamoto M; Ida H; Ohmi Y; Kitazaki T; Kikuchi Y; Yoshida S; Okamiya H; Numasaki Y; Konno T
Res Commun Mol Pathol Pharmacol; 1996 May; 92(2):155-63. PubMed ID: 8774069
[TBL] [Abstract][Full Text] [Related]
5. Antiproliferative effect of YM881 (SMANCS) on glioma cells in vitro.
Kuratsu J; Takaki S; Kochi M; Mihara Y; Ushio Y
Anticancer Res; 1991; 11(6):1957-61. PubMed ID: 1837980
[TBL] [Abstract][Full Text] [Related]
6. [Mechanism of antitumor effect of a benzoylphenylurea derivative, HO-221].
Nakajima T; Okamoto T; Masuda H; Watanabe M; Yokoyama K; Yamada N; Tsukagoshi S; Taguchi T
Gan To Kagaku Ryoho; 1990 Dec; 17(12):2345-51. PubMed ID: 2260870
[TBL] [Abstract][Full Text] [Related]
7. Role of natural killer cells and macrophages in the nonspecific resistance to tumors in mice stimulated with SMANCS, a polymer-conjugated derivative of neocarzinostatin.
Suzuki F; Pollard RB; Uchimura S; Munakata T; Maeda H
Cancer Res; 1990 Jul; 50(13):3897-904. PubMed ID: 2141295
[TBL] [Abstract][Full Text] [Related]
8. Effect of poly(adenosine diphosphate-ribose) polymerase inhibitors on neocarzinostatin-induced G2 delay in HeLa-S3 cells.
Iseki S; Mori T
Cancer Res; 1985 Sep; 45(9):4224-8. PubMed ID: 2992774
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of action of a novel macromolecular antitumor antibiotic, SN-07, on mouse leukemia L1210 cells in culture.
Yajima N; Miyata N; Kawanishi G; Katayama S; Tsukagoshi S
Jpn J Cancer Res; 1987 Oct; 78(10):1121-7. PubMed ID: 3119545
[TBL] [Abstract][Full Text] [Related]
10. [Antitumor activities of oily suspended YM881 (SMANCS) against VX2 carcinoma].
Kimura M; Konno T; Ohtsuka N; Mizumachi R; Oda T
Gan To Kagaku Ryoho; 1989 Jun; 16(6):2183-8. PubMed ID: 2544148
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of action of tetra-mu-carboxylatodirhodium(II) in L1210 tumor suspension culture.
Howard RA; Kimball AP; Bear JL
Cancer Res; 1979 Jul; 39(7 Pt 1):2568-73. PubMed ID: 445459
[TBL] [Abstract][Full Text] [Related]
12. Induction of apoptosis in murine and human neuroblastoma cell lines by the enediyne natural product neocarzinostatin.
Hartsell TL; Yalowich JC; Ritke MK; Martinez AJ; Schor NF
J Pharmacol Exp Ther; 1995 Oct; 275(1):479-85. PubMed ID: 7562588
[TBL] [Abstract][Full Text] [Related]
13. [Study on the intra-tumor tissue concentration of zinostatin stimalamer in the liver following intra-arterial injection of zinostatin stimalamer (YM881) suspension].
Toge T; Jinushi K; Sawamura A; Matsuki K
Gan To Kagaku Ryoho; 1991 Aug; 18(10):1677-80. PubMed ID: 1651687
[TBL] [Abstract][Full Text] [Related]
14. Enhancement by caffeine of neocarzinostatin cytotoxicity in murine leukemia L1210 cells.
Tatsumi K; Tashima M; Shirakawa S; Nakamura T; Uchino H
Cancer Res; 1979 May; 39(5):1623-7. PubMed ID: 154973
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of DNA polymerase from L1210 murine leukemia by a sulfhydryl reagent from agaricus bisporus.
Graham DG; Tye RW; Vogel FS
Cancer Res; 1977 Feb; 37(2):436-9. PubMed ID: 832267
[TBL] [Abstract][Full Text] [Related]
16. Neocarzinostatin-induced DNA strand scission and subsequent cell cycle traverse in HeLa S3 cells.
Berry DE; Collins JM
Cancer Res; 1980 Jul; 40(7):2405-10. PubMed ID: 6446380
[TBL] [Abstract][Full Text] [Related]
17. Antitumor activity of novel octalactin A analogs in murine leukemia cells in vitro.
Perchellet JP; Perchellet EM; Newell SW; Freeman JA; Ladesich JB; Jeong Y; Sato N; Buszek K
Anticancer Res; 1998; 18(1A):97-106. PubMed ID: 9568062
[TBL] [Abstract][Full Text] [Related]
18. Antitumor resistance induced by zinostatin stimalamer (ZSS), a polymer-conjugated neocarzinostatin (NCS) derivative. I. Meth A tumor eradication and tumor-neutralizing activity in mice pretreated with ZSS or NCS.
Masuda E; Maeda H
Cancer Immunol Immunother; 1995 May; 40(5):329-38. PubMed ID: 7600566
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxicity of smancs in comparison with other anticancer agents against various cells in culture.
Oda T; Sato F; Yamamoto H; Akagi M; Maeda H
Anticancer Res; 1989; 9(2):261-5. PubMed ID: 2526613
[TBL] [Abstract][Full Text] [Related]
20. Additive effects of bleomycin and neocarzinostatin on degradation of DNA, inhibition of DNA polymerase beta, and cell growth.
Müller WE; Maidhof A; Arendes J; Geurtsen W; Zahn RK; Schmidseder R
Cancer Res; 1979 Sep; 39(9):3768-73. PubMed ID: 89904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
